Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05467891
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-05
First Post:
2022-06-28
Brief Title:
Ribociclib And Endocrine Treatment of Physicians Choice for Locoregional Recurrent Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
Oana Danciu
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
HCRN BRE20-468
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oana Danciu
Lead Sponsor Class:
OTHER
Responsible Party:
Oana Danciu
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |